Friends For An Earlier Breast Cancer Test
Grants Program
The sponsor provides funding for pilot projects that focus on new methods to improve detection of early breast cancer and are especially interested in the development of new techniques in the areas of biological or immunologic methods of early detection.
Amount: $40,000 over 1-3 years
Deadline: December 1, 2011
Kimmel (Sidney) Foundation for Cancer Research
Kimmel Scholar Award
The goal of the program is to improve the basic understanding of cancer biology and the development of new methods for the prevention and treatment of cancer. While the majority of applications involve basic research, scientists whose work focuses on epidemiology, cancer prevention, radiation biology, pharmacology, and other clinical studies will be equally judged based on merit.
Amount: $100,000/year for 2 years
Deadline: December 1, 2011
Alex's Lemonade Stand
Innovation Awards
These grants are designed to provide critical and significant seed funding for experienced investigators with a novel and promising approach to finding causes and cures for childhood cancers.
Amount: $100,000/year for 2 years
Deadline: LOI due December 1, 2011
Alex's Lemonade Stand
Young Investigator Awards
These grants are designed as start-up funds for new scientists at the end of their fellowship training or early in their research career. Demonstration of outstanding mentorship and demonstration of a career plan that shows commitment to pediatric cancer investigation are critical components of a successful application.
Amount: $50,000/year for 2 years
Deadline: December 15, 2011
Alex's Lemonade Stand
Epidemiology Awards
These grants are designed to support the research of investigators who have a specific focus on the epidemiology, early detection, or the prevention of childhood cancer. ALSF will award support to established investigators who have a track record of peer-reviewed publications in relevant areas. These awards are expected to provide additional funds that will allow investigators to pursue novel and promising approaches to understanding the cause of childhood cancers and how such insight can be used for early detection or prevention of childhood cancer.
Amount: $100,000/year over 2 years
Deadline: December 15, 2011
American Heart Association
Clinical Research Program
Funding is available for research related to cardiovascular disease and stroke prevention or treatment, or to related clinical and public health problems, including multidisciplinary efforts. Proposals are encouraged on provider behavior, patient behavior, behavioral outcomes, risk factor outcomes, disease outcomes, cost benefit analyses, efforts to evaluate outcomes of patient care delivery and patient/provider and/or system compliance and adherence to recommendations, as well as pilot clinical research studies that may provide preliminary data for larger-scale investigation. This grant is not intended to fund basic science or to support senior researchers, but encourages mentoring of early career investigators.
Amount: $75,000/year for 2 years
Deadline: January 24, 2012
American Heart Association
Scientist Development Grant
This grant supports highly promising beginning scientists in their progress toward independence by encouraging and adequately funding research projects that can bridge the gap between completion of research training and readiness for successful competition as an independent investigator.
Amount: $77,000/year for 3 years
Deadline: January 24, 2012
American Heart Association
This grant's objective is to encourage and adequately fund the most innovative and meritorious research projects from independent investigators. The science focus includes research broadly related to cardiovascular function and disease and stroke, or to related clinical, basic science, bioengineering or biotechnology, and public health problems, including multidisciplinary efforts.
Amount: $66,000/year for 3 years
Deadline: January 24, 2012
The Lustgarten Foundation: Cure Pancreatic Cancer Now
Correlative Studies Awards Program
The Lustgarten Foundation will fund selected correlative science proposals directly linked to a CTEP sponsored clinical trial of novel therapeutics for pancreatic cancer. These correlative studies will utilize the principles routinely applied to clinical diagnostic tests, including the use of appropriate pharmacodynamic (PD) endpoints, to develop assays that will provide robust and accurate measurements of drug effects in patient specimens. Any investigator eligible to receive support from CTEP and proposing to conduct CTEP-sponsored clinical trial of a novel therapy for pancreatic cancer will be eligible to apply for funding from Lustgarten for support of correlative studies related to the trial.
Amount: Unspecified
Deadline: Applications are accepted on a rolling schedule
All grants are due into the Office of Grants and Contracts five business days prior to the sponsor's deadline for DFCI review and approval prior to submission to the sponsor.